Free Trial

Stericycle, Inc. (NASDAQ:SRCL) Receives $74.00 Average PT from Analysts

Stericycle logo with Business Services background

Stericycle, Inc. (NASDAQ:SRCL - Get Free Report) has earned a consensus rating of "Hold" from the six analysts that are presently covering the company, MarketBeat.com reports. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating and two have issued a buy rating on the company. The average 12-month price objective among analysts that have covered the stock in the last year is $74.00.

Separately, StockNews.com initiated coverage on shares of Stericycle in a report on Friday, October 11th. They issued a "hold" rating on the stock.

Get Our Latest Report on SRCL

Hedge Funds Weigh In On Stericycle

Institutional investors and hedge funds have recently bought and sold shares of the stock. Clearstead Trust LLC bought a new position in shares of Stericycle during the 1st quarter valued at approximately $25,000. GAMMA Investing LLC lifted its holdings in Stericycle by 170.9% during the first quarter. GAMMA Investing LLC now owns 818 shares of the business services provider's stock valued at $43,000 after purchasing an additional 516 shares in the last quarter. Headlands Technologies LLC bought a new position in shares of Stericycle in the first quarter worth approximately $44,000. International Assets Investment Management LLC purchased a new stake in shares of Stericycle in the second quarter worth $45,000. Finally, Quest Partners LLC raised its position in shares of Stericycle by 4,172.7% during the 2nd quarter. Quest Partners LLC now owns 940 shares of the business services provider's stock valued at $55,000 after purchasing an additional 918 shares during the period. 98.82% of the stock is currently owned by hedge funds and other institutional investors.

Stericycle Stock Performance

Shares of Stericycle stock traded up $0.01 during trading on Friday, hitting $60.90. 390,434 shares of the company's stock traded hands, compared to its average volume of 1,134,481. Stericycle has a 1 year low of $37.78 and a 1 year high of $61.77. The business has a 50-day simple moving average of $60.35 and a 200-day simple moving average of $55.99. The stock has a market capitalization of $5.65 billion, a P/E ratio of 160.26, a PEG ratio of 3.32 and a beta of 1.11. The company has a debt-to-equity ratio of 0.55, a current ratio of 1.13 and a quick ratio of 1.13.

Stericycle (NASDAQ:SRCL - Get Free Report) last announced its quarterly earnings results on Thursday, July 25th. The business services provider reported $0.61 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.57 by $0.04. Stericycle had a net margin of 1.37% and a return on equity of 7.94%. The firm had revenue of $661.60 million for the quarter, compared to the consensus estimate of $672.07 million. As a group, analysts forecast that Stericycle will post 2.29 EPS for the current year.

About Stericycle

(Get Free Report

Stericycle, Inc, together with its subsidiaries, provides regulated waste and compliance services in the United States, Europe, and internationally. The company offers regulated waste and compliance services, including regulated medical waste, sharps waste management and disposal, pharmaceutical waste management and disposal, chemotherapy waste and disposal, controlled substance waste disposal, healthcare hazardous waste, and integrated waste stream solutions; specialty services, such as MedDrop medication collection kiosks, safe community solutions, SafeDrop sharps mailback solutions, and airport and maritime waste services; medical supply store services, that includes sharps and disposable biohazardous waste containers, infection control supplies, and seal&send medication mail back; and compliance solutions including Steri-Safe compliance solutions.

Recommended Stories

Analyst Recommendations for Stericycle (NASDAQ:SRCL)

Should you invest $1,000 in Stericycle right now?

Before you consider Stericycle, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Stericycle wasn't on the list.

While Stericycle currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Elon Musk's Next Move Cover

Wondering when you'll finally be able to invest in SpaceX, StarLink, or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Billionaires Bet Big on Cavco and Champion Homes
3 Momentum Stock Picks With Room to Run
Champion Homes’ 37% Sales Surge: Time to Invest?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines